Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

COVID-19 “Round 2” – Findings & way forward (Kearney)

22 June 2020

Report

Why is Now the Right Time to Modernise the Eu Variations System?

30 January 2020

Report

AMR Industry Alliance 2020 Progress Report

16 January 2020

Report

Overarching recommendations for improved access to generic and biosimilar medicines in the hospital setting

7 October 2019

Report

Improving healthcare delivery in hospitals by optimized utilization of medicines

7 October 2019

Report

Addressing medicine shortages in Europe

29 September 2017

Report

Position paper Reading list Commentary + EIU document

Global Healthcare Trends and Outlook

15 June 2017

Report

Market Review – European Generic Medicines Markets 2016

10 November 2016

Report